Eric Johnsson

Swede Down Under. Life sciences policy @MedicinesAus, formerly @NHSuk and @BIA_UK

[Eric Johnsson @johnsson_eric]

Proud to see the foundations laid by the @BIA_UK Antibody Taskforce during the start of the pandemic come to fruition through RQ Bio's licensing agreement with AstraZeneca.

Read about how the Taskforce was set up at pace during times of crisis here: https://t.co/hMxW8eqTWt

[BioIndustry Association (BIA) @BIA_UK]

Today RQ Bio has announced a licencing agreement with @AstraZeneca for its portfolio of early-stage monoclonal #antibodies targeted against SARS-CoV-2 🦠

Read the full response ⤵️
https://t.co/OFdR6rxCIJ

[Martin Turner @DrMartinTurner]

Of the many out-of-the-ordinary things we did at @BIA_UK during the pandemic, this industry-academia R&D consortium that led to the creation of a new company now partnered with AZ was among the most exciting. @johnsson_eric did us proud steering the whole process.

[Eric Johnsson @johnsson_eric]

The National Medicines Policy is too important to be rushed. This is a great outcome for all Australians.

[Medicines Australia @MedicinesAus]

BREAKING: National Medicines Policy (#NMP) Review will be paused until after the federal election. This follows the call from Medicines Australia, patient groups, health bodies, and industry to allow more time for consultation and feedback. https://t.co/a8F3H28s5V

#auspol

[Garvan Institute of Medical Research @GarvanInstitute]

$61 million grant to fast-track treatments for rare and ‘untreatable’ cancers from lab to clinic to industry. Announced by @GregHuntMP and @AngusTaylorMP today. This is part of a $185 million project led by @OmicoAustralia @ProfDMThomas https://t.co/yn6rHsMBD0

[End COVID For All @EndCOVIDForAll]

Good news this morning!🙌

This vital investment will help fund @CEPIvaccines mission to tackle future epidemics & pandemics faster, potentially saving millions of lives + trillions of $ in lost economic output.

Thank you @ScottMorrisonMP & @MarisePayne

#EndCOVIDforAll #auspol

[Eric Johnsson @johnsson_eric]

This is a great opportunity for anyone interested in learning how to bring biotech/pharma innovations to market! Apply today for the fully-funded Bridge Program, which is proudly supported by @MedicinesAus. #drugdiscovery #commercialisation @program_bridge

[The Bridge Program @program_bridge]

Applications for our 2022 program are now open! Want to bring new #pharmaceuticals to market? Apply for our fully-funded training program: https://t.co/fN6tPn6Qsu @MTPConnect_AUS

[Eric Johnsson @johnsson_eric]

The #TRIPSwaiver will not address the real challenges to vaccinating the world. Rather, eliminating trade barriers, addressing supply chains bottlenecks, and sharing more vaccines will boost inoculations in developing countries. @MedicinesAus @AusBiotech
https://t.co/vNMVwhmPig

[Eric Johnsson @johnsson_eric]

Thrilled to have joined the great team @MedicinesAus just as we signed a new Strategic Agreement with the Government, paving way for a stronger patient voice in how medicines are made available in Australia. Exciting times ahead! #MedicinesMatter

[Medicines Australia @MedicinesAus]

Medicines Australia’s 5-year Strategic Agreement has been signed with the Australian Government, making way for stronger patient involvement in how new medicines are made available in Australia. #MedicinesMatter

https://t.co/8HLARxuk1i

[Martin Turner @DrMartinTurner]

This report lifts the lid on why the UK excels in #genomics and #biotech more generally. It's full of great stats and analysis from the author @johnsson_eric and many others. #GenomicsNation.

[Eric Johnsson @johnsson_eric]

Pleased to have led this project for @BIA_UK in partnership with @sangerinstitute & @MedDiscCat to benchmark the UK #genomics sector and highlight the tremendous opportunity it represents for investors, patients and the UK economy. Do take a look!

[BioIndustry Association (BIA) @BIA_UK]

We are excited to publish a new report in partnership @sangerinstitute and @MedDiscCat which showcases the strength, breadth and opportunity of the UK’s #genomics sector for investors, patients and the UK economy.

Key findings below 👇
https://t.co/eZJCDJL9Lo

#GenomicsNation

[Eric Johnsson @johnsson_eric]

Check out my @BIA_UK blog for more details on the story of the Taskforce and its key learnings: https://t.co/hMxW8eIvl3

[Eric Johnsson @johnsson_eric]

During the first #COVID19 wave, @BIA_UK set up the BIA Antibody Taskforce - a consortium of industry, academia + charities.
The mission? Identify, develop and dose patients with neutralising antibodies to #SARSCoV2 in < 9 months.
The outcome & lessons learnt? Thread below 1/12

[Eric Johnsson @johnsson_eric]

Final thought: this was all about people. They came together at speed in an open & collaborative way, contributed expertise + resources, and worked tirelessly to find a solution to #COVID19. I’m proud to have worked alongside experts who’re committed to making a difference. 12/12